LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) Files An 8-K Regulation FD Disclosure
Item 7.01
| Regulation FD Disclosure |
A copy of the news release announcing that the successful
development and initial trial of the industrys first zero-sugar
cannabinoid / pterostilbene edible tablet utilizing both
Neutriscis and Lexarias proprietary and patented technologies is
filed as exhibit 99.1 to this current report and is hereby
incorporated by reference.
| Item 9.01 | Financial Statements and Exhibits |
| 99.1 | Press Release dated January 19, 2017 |
– 2 –
About LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP)
Lexaria Bioscience Corp., formerly Lexaria Corp., is a food sciences company. The Company is focused on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its infusion technologies. Its food sciences activities include the development of its nutrient infusion technologies for the production of superfoods, and the production of food products under its two consumer product brands, ViPova and Lexaria Energy. Its technology is developed to aid absorption and bioavailability of various payload molecules, including cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC). Its range of flavors to the ViPova family, are available in 8 to 32 bag portions: Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light. It produces and sells edible consumer products infused with cannabidiol and available for sale in over 50 states. LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) Recent Trading Information
LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) closed its last trading session down -0.013 at 0.567 with 1,348,097 shares trading hands.